Looking for our Business Solutions? Click here:CloudQuote APIsContact Us
Home
Stocks in the NewsMost Active StocksPercent GainersPercent LosersFollowed Stocks
,

Latest News

The Smartest Dividend Stocks in Bill Ackman's Portfolio to Buy With $1,000 Right Nowfool.com
Via The Motley Fool · May 12, 2025
6 Great Warren Buffett Quotes That All Retirees Should Read in 2025fool.com
Via The Motley Fool · May 12, 2025
CCK Q1 Earnings Call: Crown Holdings Raises Outlook as Beverage Can Volumes Drive Margin Expansion
Metal packaging products manufacturer Crown Holdings (NYSE:CCK) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 3.7% year on year to $2.89 billion. Its non-GAAP profit of $1.67 per share was 35.4% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Upland’s (NASDAQ:UPLD) Q1: Beats On Revenue, Stock Soars
Business automation software provider Upland Software (NASDAQ: UPLD) beat Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 10% year on year to $63.66 million. On the other hand, next quarter’s revenue guidance of $53.3 million was less impressive, coming in 11.7% below analysts’ estimates. Its non-GAAP profit of $0.23 per share was 32.7% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
A Look Ahead: Eton Pharmaceuticals's Earnings Forecastbenzinga.com
Via Benzinga · May 12, 2025
A Look Ahead: Herbalife's Earnings Forecastbenzinga.com
Via Benzinga · May 12, 2025
An Overview of Intuitive Machines's Earningsbenzinga.com
Via Benzinga · May 12, 2025
Pound Sterling Plummets Against US Dollar As US-China Deals To Lower Tariffstalkmarkets.com
The Pound Sterling falls sharply below 1.3200 against the US Dollar after the US and China agree to reduce tariffs for 90 days by 115%.
Via Talk Markets · May 12, 2025
CDNS Q1 Earnings Call: AI and IP Expansion Lift Cadence’s Results and Outlook
Semiconductor design software provider Cadence Design Systems (NASDAQ:CDNS) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 23.1% year on year to $1.24 billion. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $5.19 billion at the midpoint. Its non-GAAP profit of $1.57 per share was 4.9% above analysts’ consensus estimates.
Via StockStory · May 12, 2025
Blade Beats Q1 Forecasts As Jet Surge, Short Flights Drive Gainsbenzinga.com
Blade Air Mobility Inc. (NASDAQ:BLDE) trading higher on better-than-expected Q1 2025 results with revenue of $54.3M and growth in Passenger segment. FY 2025 outlook includes double-digit adjusted EBITDA.
Via Benzinga · May 12, 2025
Earnings Outlook For DoubleDown Interactivebenzinga.com
Via Benzinga · May 12, 2025
What to Expect from Landstar System's Earningsbenzinga.com
Via Benzinga · May 12, 2025
A Glimpse of Loar Holdings's Earnings Potentialbenzinga.com
Via Benzinga · May 12, 2025
Earnings Outlook For CAEbenzinga.com
Via Benzinga · May 12, 2025
An Overview of Camtek's Earningsbenzinga.com
Via Benzinga · May 12, 2025
Spotlight on Eaton Corp: Analyzing the Surge in Options Activitybenzinga.com
Via Benzinga · May 12, 2025
Breaking Down Dentsply Sirona: 9 Analysts Share Their Viewsbenzinga.com
Via Benzinga · May 12, 2025
Nasdaq Surges Over 3%; Fox Posts Upbeat Q3 Resultsbenzinga.com
Via Benzinga · May 12, 2025
Earnings Outlook For Under Armourbenzinga.com
Via Benzinga · May 12, 2025
Where Harrow Stands With Analystsbenzinga.com
Via Benzinga · May 12, 2025
Alcon Earnings Previewbenzinga.com
Via Benzinga · May 12, 2025
Earnings Outlook For On Holdingbenzinga.com
Via Benzinga · May 12, 2025
Forecasting The Future: 5 Analyst Projections For Super Group (SGHC)benzinga.com
Via Benzinga · May 12, 2025
5 Analysts Assess United States Antimony: What You Need To Knowbenzinga.com
Via Benzinga · May 12, 2025
S&P 500, Dow Jones Pharma Stocks Boomerang As Trump Threatens Drug-Price Reforminvestors.com
It's still unclear how President Donald Trump plans to tie drug prices in the U.S. to international prices.
Via Investor's Business Daily · May 12, 2025